Last month, Europe’s Committee for Medicinal Products for Human Use approved a gene therapy for a rare genetic disease, the first time a Western regulatory agency has okayed such a treatment, though gene therapies have been approved in China.
The first regulatory approval of a gene therapy treatment could spark broader patient access to the technology.
View the original article here: Gene Therapy on the Mend